AlphaYouJE
Insider selling
Jeff E. Knight sold $3.4M of Crinetics Pharmaceuticals, Inc. (CRNX) stock
Jeff E. Knight, Chief Dev. & Operating Officer of Crinetics Pharmaceuticals, Inc. (CRNX), sold 85,163 shares of CRNX stock worth $3.4M, per an SEC Form 4 filed Apr 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Apr 8, 2026, 2 days before it was made public.
- Traded
- Apr 8, 2026
- Disclosed
- Apr 10, 2026
- Filing delay
- 2 days
- Role
- Chief Dev. & Operating Officer
- Source
- SEC Form 4
More CRNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.